Gelonghui, April 7 | Fu'an Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. recently received a drug registration certificate issued by the State Drug Administration. Drug name: nimegoline tablets. Nimergoline tablets are suitable for improving low motivation due to the sequelae of a stroke; they are also suitable for vascular dementia. In particular, during early treatment, they improve cognition, memory, etc., and can reduce the severity of the disease.
福安药业(300194.SZ)：尼麦角林片收到药品注册证书
Fuan Pharmaceutical (300194.SZ): Nimergoline tablets received a drug registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.